Literature DB >> 12600821

Cytokine-chemokine networks in experimental mycobacterial and schistosomal pulmonary granuloma formation.

Bo-Chin Chiu1, Christine M Freeman, Valerie R Stolberg, Eric Komuniecki, Pamela M Lincoln, Steven L Kunkel, Stephen W Chensue.   

Abstract

Type-1 and type-2 lung granulomas, respectively, elicited by bead immobilized Mycobacteria bovis and Schistosoma mansoni egg antigens (Ags) display different patterns of chemokine expression. This study tested the hypothesis that chemokine expression patterns were related to upstream cytokine signaling. Using quantitative transcript analysis, we defined expression profiles for 16 chemokines and then examined the in vivo effects of neutralizing antibodies against interferon-gamma (IFN-gamma), interleukin (IL)-4, IL-10, IL-12, and IL-13. Transcripts for CXCL2, -5, -9, -10, and -11 and the CCL chemokine, CCL3, and lymphotactin (XCL1), were largely enhanced by Th1-related cytokines, IFN-gamma or IL-12. Transcripts for CCL11, CCL22, CCL17, and CCL1 were enhanced largely by Th2-related cytokines, IL-4, IL-10, or IL-13. Transcripts for CCL4, CCL2, CCL8, CCL7, and CCL12 were potentially induced by either Th1- or Th2-related cytokines, although some of these showed biased expression. IFN-gamma and IL-4 enhanced the greatest complement of transcripts, and their neutralization had the greatest anti-inflammatory effect on type-1 and type-2 granulomas, respectively. Th1/Th2 cross-regulation was evident because endogenous Th2 cytokines inhibited type-1, whereas Th1 cytokines inhibited type-2 biased chemokines. These findings reveal a complex cytokine-chemokine regulatory network that dictates profiles of local chemokine expression during T cell-mediated granuloma formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12600821      PMCID: PMC3677198          DOI: 10.1165/rcmb.2002-0241OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  35 in total

Review 1.  T helper cell populations, cytokine dynamics, and pathology of the schistosome egg granuloma.

Authors:  D L Boros
Journal:  Microbes Infect       Date:  1999-06       Impact factor: 2.700

2.  Monocyte chemoattractant protein (MCP)-4 expression in the airways of patients with asthma. Induction in epithelial cells and mononuclear cells by proinflammatory cytokines.

Authors:  B Lamkhioued; E A Garcia-Zepeda; S Abi-Younes; H Nakamura; S Jedrzkiewicz; L Wagner; P M Renzi; Z Allakhverdi; C Lilly; Q Hamid; A D Luster
Journal:  Am J Respir Crit Care Med       Date:  2000-08       Impact factor: 21.405

3.  Population analysis of CD4+ T cell chemokine receptor transcript expression during in vivo type-1 (mycobacterial) and type-2 (schistosomal) immune responses.

Authors:  Bo-Chin Chiu; Xiao-Zhou Shang; Valerie R Stolberg; Eric Komuniecki; Stephen W Chensue
Journal:  J Leukoc Biol       Date:  2002-08       Impact factor: 4.962

4.  Chemokine production by the BEAS-2B human bronchial epithelial cells: differential regulation of eotaxin, IL-8, and RANTES by TH2- and TH1-derived cytokines.

Authors:  T Fujisawa; Y Kato; J Atsuta; A Terada; K Iguchi; H Kamiya; H Yamada; T Nakajima; M Miyamasu; K Hirai
Journal:  J Allergy Clin Immunol       Date:  2000-01       Impact factor: 10.793

5.  Interleukin 4 and 13 participation in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation: multiparameter analysis of cellular recruitment, chemokine expression and cytokine networks.

Authors:  J H Ruth; K S Warmington; X Shang; P Lincoln; H Evanoff; S L Kunkel; S W Chensue
Journal:  Cytokine       Date:  2000-05       Impact factor: 3.861

6.  Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines.

Authors:  J L Pype; L J Dupont; P Menten; E Van Coillie; G Opdenakker; J Van Damme; K F Chung; M G Demedts; G M Verleden
Journal:  Am J Respir Cell Mol Biol       Date:  1999-10       Impact factor: 6.914

7.  Expression of C-C chemokine TARC in human nasal mucosa and its regulation by cytokines.

Authors:  N Terada; T Nomura; W J Kim; Y Otsuka; R Takahashi; H Kishi; T Yamashita; N Sugawara; S Fukuda; T Ikeda-Ito; A Konno
Journal:  Clin Exp Allergy       Date:  2001-12       Impact factor: 5.018

8.  Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation.

Authors:  B Qiu; K A Frait; F Reich; E Komuniecki; S W Chensue
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

9.  The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3.

Authors:  P Loetscher; A Pellegrino; J H Gong; I Mattioli; M Loetscher; G Bardi; M Baggiolini; I Clark-Lewis
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

10.  Eosinophil recruitment in type-2 hypersensitivity pulmonary granulomas: source and contribution of monocyte chemotactic protein-3 (CCL7).

Authors:  Xiao-Zhou Shang; Bo-Chin Chiu; Valerie Stolberg; Nicholas W Lukacs; Steven L Kunkel; Hedwig S Murphy; Stephen W Chensue
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

View more
  30 in total

1.  T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.

Authors:  Edward S Chen; Jan Wahlström; Zhimin Song; Matthew H Willett; Maria Wikén; Rex C Yung; Erin E West; John F McDyer; Ying Zhang; Anders Eklund; Johan Grunewald; David R Moller
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

2.  Cysteine-cysteinyl chemokine receptor 6 mediates invariant natural killer T cell airway recruitment and innate stage resistance during mycobacterial infection.

Authors:  Valerie R Stolberg; Bo-chin Chiu; Brian E Martin; Samir A Shah; Matyas Sandor; Stephen W Chensue
Journal:  J Innate Immun       Date:  2010-10-29       Impact factor: 7.349

3.  Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide.

Authors:  Carmen M Swaisgood; Kyra Oswald-Richter; Stephen D Moeller; Jennifer M Klemenc; Lisa M Ruple; Carol F Farver; John M Drake; Daniel A Culver; Wonder P Drake
Journal:  Am J Respir Cell Mol Biol       Date:  2010-03-26       Impact factor: 6.914

4.  CC chemokine receptor 4 contributes to innate NK and chronic stage T helper cell recall responses during Mycobacterium bovis infection.

Authors:  Valerie R Stolberg; Bo-Chin Chiu; Brian M Schmidt; Steven L Kunkel; Matyas Sandor; Stephen W Chensue
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

5.  Global gene expression profile progression in Gaucher disease mouse models.

Authors:  You-Hai Xu; Li Jia; Brian Quinn; Matthew Zamzow; Keith Stringer; Bruce Aronow; Ying Sun; Wujuan Zhang; Kenneth D R Setchell; Gregory A Grabowski
Journal:  BMC Genomics       Date:  2011-01-11       Impact factor: 3.969

6.  Therapeutic DNA vaccine reduces schistosoma mansoni-induced tissue damage through cytokine balance and decreased migration of myofibroblasts.

Authors:  Fabiani Gai Frantz; Toshihiro Ito; Karen Angélica Cavassani; Cory M Hogaboam; Célio Lopes Silva; Steven L Kunkel; Lúcia H Faccioli
Journal:  Am J Pathol       Date:  2011-05-18       Impact factor: 4.307

7.  EAE mediated by a non-IFN-γ/non-IL-17 pathway.

Authors:  Mark A Kroenke; Stephen W Chensue; Benjamin M Segal
Journal:  Eur J Immunol       Date:  2010-08       Impact factor: 5.532

8.  Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis.

Authors:  Melissa L Burke; Donald P McManus; Grant A Ramm; Mary Duke; Yuesheng Li; Malcolm K Jones; Geoffrey N Gobert
Journal:  PLoS Negl Trop Dis       Date:  2010-02-09

9.  Co-ordinated gene expression in the liver and spleen during Schistosoma japonicum infection regulates cell migration.

Authors:  Melissa L Burke; Donald P McManus; Grant A Ramm; Mary Duke; Yuesheng Li; Malcolm K Jones; Geoffrey N Gobert
Journal:  PLoS Negl Trop Dis       Date:  2010-05-18

10.  The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells.

Authors:  Edward J Kerschen; Donald A Cohen; Alan M Kaplan; Susan C Straley
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.